Related Experiment Video
Updated: Jan 10, 2026
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
13.1K
A Panel Management Approach Using Prescription Drug Monitoring Program Data for Primary Care Patients with Chronic
Constance van Eeghen1, Marianne Burke1, Zoe Daudier2
1University of Vermont.
Research Square
|November 24, 2025
Summary
Primary care clinicians can use Prescription Drug Monitoring Program (PDMP) data to generate reports for managing patients on long-term opioid therapy. This study found PDMP data feasible for improving chronic pain management and opioid prescribing practices.
Area of Science:
- Primary Care Medicine
- Health Informatics
- Pain Management
Background:
- Explores a novel process for primary care clinicians to enhance chronic pain management.
- Focuses on improving opioid prescribing practices through data utilization.
Purpose of the Study:
- Assess the feasibility of using state-based Prescription Drug Monitoring Program (PDMP) data.
- Evaluate the value of panel management reports for patients on long-term opioid therapy.
Main Methods:
- Study conducted in four rural primary care clinics.
- Assessed feasibility of downloading and utilizing PDMP data.
- Examined the perceived value of panel management reports from PDMP and EHR data.
Main Results:
- Downloading PDMP data was feasible and efficient across all sites.
- EHR review presented challenges due to data inconsistencies.
- Clinicians found PDMP data easy to generate and reports informative for identifying high-risk patients.
Conclusions:
- PDMP data shows potential for panel management reports in chronic opioid therapy.
- Further research is needed to confirm the effectiveness of these reports in improving patient care and safety.
Related Concept Videos
01:25Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
892
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
892
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
818
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
818
01:26Methods of Documentation II: POMR
1.3K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.3K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
138
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
138
01:12Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659